How Pfizer Inc. stacks up

PFE · against 24 other Healthcare companies of similar size

Overall

45/ 100

Near the bottom of its peers.

Ranked #22 of 25 · scores higher than 8% of peers

Bars: peers in each 10-point band of the overall score

4 peers with an overall score of 40–49, including PFE · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#11 of 25Score 66 / 100 · beats 54%Growth#24 of 25Score 14 / 100 · beats 4%Profitability#17 of 25Score 68 / 100 · beats 25%Risk#10 of 25Higher relative risk · safety 33 · beats 63%

Ranking by overall score

Top 5 and the companies ranked around PFE

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Novo Nordisk A/SNVO · US-listed	177.5B USD	71	92	60	99	2 / 2
2	Vertex Pharmaceuticals IncorporatedVRTX · US-listed	134.5B USD	70	55	58	96	0 / 2
3	Regeneron Pharmaceuticals, Inc.REGN · US-listed	100.2B USD	68	61	49	85	0 / 2
4	GSK plcGSK · US-listed	97.5B USD	67	87	72	89	2 / 2
5	SanofiSNY · US-listed	108.6B USD	66	88	55	72	1 / 2
⋯
18	Elevance Health, Inc.ELV · US-listed	89.7B USD	50	76	45	52	2 / 2
20	CVS Health CorporationCVS · US-listed	116.9B USD	47	70	49	44	2 / 2
20	Thermo Fisher Scientific Inc.TMO · US-listed	258.2B USD	47	53	44	71	2 / 2
22	Abbott LaboratoriesABT · US-listed	189.3B USD	45	57	26	68	2 / 2
22	Pfizer Inc.PFE · US-listed	171.0B USD	45	66	14	68	2 / 2
24	Gilead Sciences, Inc.GILD · US-listed	207.7B USD	18	8	26	30	2 / 2
24	Moderna, Inc.MRNA · US-listed	91.2B USD	18	8	5	14	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…